Vorasidenib
FDA approves first ever T-cell receptor gene therapy from Adaptimmune, Servier’s brain tumor pill

FDA approves first ever T-cell receptor gene therapy from Adaptimmune, Servier’s brain tumor pill

This week, Adaptimmune clinched gold when it secured the first-ever US Food and Drug Administration (FDA) approval for a T-cell...

Impressions : 1171

Nanoparticles in Pfizer’s vaccine may be triggering allergic reactions; FDA declines nod to Novartis’ blockbuster

This week, Phispers brings you more updates on the coronavirus pandemic. The ‘fast spreading’ UK mutation of the co...

Impressions : 2986